Israel Englander Immunovant, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Immunovant, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 147,097 shares of IMVT stock, worth $4.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

147,097

Previous 376,507 60.93%

Holding current value

$4.05 Million

Previous $10.4 Million 60.93%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	N/A	-229,410 Reduced 60.93%	147,097 $4.05 Million
Q3 2024 Nov 14, 2024	BUY	$27.51 - $27.51 $2.78 Million - $2.78 Million	101,155 Added 36.74%	376,507 $10.4 Million
Q2 2024 Aug 14, 2024	SELL	$25.1 - $31.61 $4.61 Million - $5.81 Million	-183,675 Reduced 40.01%	275,352 $7.27 Million
Q1 2024 May 15, 2024	SELL	$30.27 - $43.79 $6.43 Million - $9.3 Million	-212,374 Reduced 31.63%	459,027 $14.8 Million
Q4 2023 Feb 14, 2024	BUY	$31.31 - $44.19 $3.83 Million - $5.4 Million	122,255 Added 22.26%	671,401 $28.3 Million
Q2 2023 Aug 14, 2023	SELL	$14.2 - $23.75 $7.58 Million - $12.7 Million	-533,756 Reduced 49.29%	549,146 $10.4 Million
Q1 2023 May 15, 2023	BUY	$15.27 - $19.72 $15.3 Million - $19.7 Million	1,000,461 Added 1213.55%	1,082,902 $16.8 Million
Q4 2022 Feb 14, 2023	SELL	$6.59 - $17.75 $1.07 Million - $2.89 Million	-162,816 Reduced 66.39%	82,441 $1.46 Million
Q3 2022 Nov 14, 2022	SELL	$3.93 - $6.37 $347,003 - $562,445	-88,296 Reduced 26.47%	245,257 $1.37 Million
Q2 2022 Aug 15, 2022	SELL	$3.38 - $5.65 $888,017 - $1.48 Million	-262,727 Reduced 44.06%	333,553 $1.3 Million
Q1 2022 May 16, 2022	BUY	$5.06 - $8.77 $1.31 Million - $2.27 Million	258,312 Added 76.43%	596,280 $3.29 Million
Q4 2021 Feb 14, 2022	BUY	$7.33 - $9.32 $953,207 - $1.21 Million	130,042 Added 62.54%	337,968 $2.88 Million
Q3 2021 Nov 15, 2021	SELL	$7.01 - $11.37 $2.02 Million - $3.28 Million	-288,497 Reduced 58.12%	207,926 $1.81 Million
Q2 2021 Aug 16, 2021	BUY	$9.4 - $16.85 $624,733 - $1.12 Million	66,461 Added 15.46%	496,423 $5.25 Million
Q1 2021 May 17, 2021	BUY	$13.08 - $49.6 $114,816 - $435,388	8,778 Added 2.08%	429,962 $6.9 Million
Q4 2020 Feb 16, 2021	SELL	$36.36 - $52.71 $5.54 Million - $8.03 Million	-152,279 Reduced 26.55%	421,184 $19.5 Million
Q3 2020 Nov 16, 2020	BUY	$22.61 - $38.9 $2.63 Million - $4.53 Million	116,329 Added 25.45%	573,463 $20.2 Million
Q2 2020 Aug 14, 2020	BUY	$13.87 - $28.44 $804 - $1,649	58 Added 0.01%	457,134 $11.1 Million
Q1 2020 May 14, 2020	BUY	$8.36 - $17.13 $3.82 Million - $7.83 Million	457,076 New	457,076 $7.11 Million

Others Institutions Holding IMVT

# of Institutions

218

Shares Held

67.1M

Call Options Held

2.48M

Put Options Held

561K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account